bd 1047 has been researched along with uridine triphosphate in 1 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (uridine triphosphate) | Trials (uridine triphosphate) | Recent Studies (post-2010) (uridine triphosphate) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 2,423 | 20 | 331 |
| Protein | Taxonomy | bd 1047 (IC50) | uridine triphosphate (IC50) |
|---|---|---|---|
| P2Y purinoceptor 2 | Mus musculus (house mouse) | 1.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behensky, A; Cuevas, J; Katnik, C; Rodriguez, A | 1 |
1 other study(ies) available for bd 1047 and uridine triphosphate
| Article | Year |
|---|---|
Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors.
Topics: Adenosine Triphosphate; Animals; Anti-Anxiety Agents; Benzimidazoles; Brain Ischemia; Butyrates; Calcium; Cell Death; Cell Survival; Ethylenediamines; Female; Membrane Potentials; Microglia; Morpholines; Patch-Clamp Techniques; Piperazines; Pregnancy; Purinergic P2X Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Tropanes; Uridine Triphosphate | 2011 |